Jeffrey Bacha
Chairman chez RAKOVINA THERAPEUTICS INC.
Fortune : 404 898 $ au 31/03/2024
Profil
Jeffrey A.
Bacha was the founder of Kintara Therapeutics, Inc. (founded in 2009) and Del Mar Pharmaceuticals (BC) Ltd.
(founded in 2010), where he holds the titles of Director and President, Chief Executive Officer & Director respectively.
He currently holds the position of Chief Executive Officer & Director at Edison Oncology Holding Corp., CEO, Chief Financial Officer & Director at NewGen Therapeutics, Inc., Executive Chairman at Rakovina Therapeutics, Inc., Director at Leukemia & Lymphoma Society Greater San Francisco Bay Area, Independent Director at AD4 Capital Corp., and Member-Research Roundtable at National Brain Tumor Society, Inc. Mr. Bacha's former positions include President & Chief Executive Officer at Inimex Pharmaceuticals, Inc., Chairman at Covenant House Vancouver, Independent Director at Sernova Corp., Director at CalEthos, Inc., Director & Senior Manager at KPMG Health Ventures, Founding Director at Urigen Holdings, Inc., Vice President-Corporate Development at EACOM Timber Corp., Chief Operating Officer & Executive Vice President at Clerac LLC, Chief Financial Officer & VP-Corporate Development at XBiotech USA, Inc., and Chief Operating Officer & EVP-Corporate Affairs at Clera Inc. Mr. Bacha obtained his undergraduate degree from the University of California San Diego in 1991 and his MBA from Goizueta Business School-Emory in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SERNOVA CORP.
0,20% | 25/04/2023 | 614 980 ( 0,20% ) | 252 757 $ | 31/03/2024 |
| 19/04/2024 | 1 822 857 ( 2,80% ) | 134 891 $ | 31/03/2024 | |
AD4 CAPITAL CORP.
1,61% | 31/10/2022 | 250 000 ( 1,61% ) | 17 250 $ | 31/03/2024 |
Postes actifs de Jeffrey Bacha
| Sociétés | Poste | Début |
|---|---|---|
| RAKOVINA THERAPEUTICS INC. | Chairman | 01/12/2020 |
| AD4 CAPITAL CORP. | Director/Board Member | 23/06/2021 |
| Leukemia & Lymphoma Society Greater San Francisco Bay Area | Director/Board Member | - |
National Brain Tumor Society, Inc.
 National Brain Tumor Society, Inc. Miscellaneous Commercial ServicesCommercial Services National Brain Tumor Society, Inc. operates a foundation focused on brain tumor treatment. The company was founded by G. Bonnie Feldman in 2008 and is headquartered in Newton, MA. | Corporate Officer/Principal | - |
NewGen Therapeutics, Inc.
 NewGen Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology NewGen Therapeutics, Inc. engages in the provision of research and development services. The company is headquartered in Menlo Park, CA. | Chief Executive Officer | - |
Edison Oncology Holding Corp.
 Edison Oncology Holding Corp. Financial ConglomeratesFinance Edison Oncology Holding Corp. operates as biopharmaceutical firm. The company was founded in 2018 and is headquartered in Menlo Park, CA. | Chief Executive Officer | - |
Del Mar Pharmaceuticals (BC) Ltd.
 Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Part of Kintara Therapeutics, Inc., Del Mar Pharmaceuticals (BC) Ltd. provides drug development services. The private company is based in Vancouver, Canada. The Canadian company was founded by William James Garner, Jeffrey A. Bacha, Dennis M. Brown. Jeffrey A. Bacha has been the CEO since incorporation. Del Mar Pharmaceuticals (BC was acquired by Kintara Therapeutics, Inc. on January 25, 2013 for $0.65 million. | Founder | 18/10/2010 |
Anciens postes connus de Jeffrey Bacha
| Sociétés | Poste | Fin |
|---|---|---|
| SERNOVA CORP. | Director/Board Member | 01/01/2022 |
| KINTARA THERAPEUTICS, INC. | Chief Executive Officer | 07/11/2017 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jeffrey Bacha
| University of California San Diego | Undergraduate Degree |
| Goizueta Business School-Emory | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SERNOVA CORP. | Health Technology |
| KINTARA THERAPEUTICS, INC. | Health Technology |
| CALETHOS, INC. | Finance |
| RAKOVINA THERAPEUTICS INC. | Finance |
| Entreprise privées | 14 |
|---|---|
EACOM Timber Corp.
 EACOM Timber Corp. Forest ProductsNon-Energy Minerals EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada. | Non-Energy Minerals |
Inimex Pharmaceuticals, Inc.
 Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
Clerac LLC
 Clerac LLC Finance/Rental/LeasingFinance Clerac LLC provides car rental services. It also serves airport markets. The company is headquartered in Westlake, OH. | Finance |
| Leukemia & Lymphoma Society Greater San Francisco Bay Area | |
| KPMG Health Ventures | |
Covenant House Vancouver
 Covenant House Vancouver Services to the Health IndustryHealth Services Covenant House Vancouver provides shelter and services to children and youth. It offers homeless, runaway and at-risk youth between the ages of 16 and 24 with short-term residential care through its crisis program. The company was founded on September 22, 1997 and is headquartered in Vancouver, Canada. | Health Services |
XBiotech USA, Inc.
 XBiotech USA, Inc. BiotechnologyHealth Technology Part of XBiotech, Inc., XBiotech USA, Inc. is a private company that manufactures antibodies. The company is based in Austin, TX. The company was founded in 2005. The CEO is John Simard. | Health Technology |
National Brain Tumor Society, Inc.
National Brain Tumor Society, Inc. Miscellaneous Commercial ServicesCommercial Services National Brain Tumor Society, Inc. operates a foundation focused on brain tumor treatment. The company was founded by G. Bonnie Feldman in 2008 and is headquartered in Newton, MA. | Commercial Services |
Del Mar Pharmaceuticals (BC) Ltd.
Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Part of Kintara Therapeutics, Inc., Del Mar Pharmaceuticals (BC) Ltd. provides drug development services. The private company is based in Vancouver, Canada. The Canadian company was founded by William James Garner, Jeffrey A. Bacha, Dennis M. Brown. Jeffrey A. Bacha has been the CEO since incorporation. Del Mar Pharmaceuticals (BC was acquired by Kintara Therapeutics, Inc. on January 25, 2013 for $0.65 million. | Health Technology |
| Urigen Holdings, Inc. | |
Clera Inc.
 Clera Inc. Miscellaneous Commercial ServicesCommercial Services Clera Inc. operates as a drug discovery and development company that creates medicines for aging related illness of the mind. It targets aging related markets of Parkinson’s disease, cognition, Alzheimer’s and depression. The company was founded by Robley L. Seeman and Philip Seeman in 2001 and is headquartered in Toronto, Canada. | Commercial Services |
Edison Oncology Holding Corp.
Edison Oncology Holding Corp. Financial ConglomeratesFinance Edison Oncology Holding Corp. operates as biopharmaceutical firm. The company was founded in 2018 and is headquartered in Menlo Park, CA. | Finance |
NewGen Therapeutics, Inc.
NewGen Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology NewGen Therapeutics, Inc. engages in the provision of research and development services. The company is headquartered in Menlo Park, CA. | Health Technology |
| AD4 Capital Corp. |
